Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS/MS technology

Journal of Pharmaceutical and Biomedical Analysis

Volumn 86, Issue , 2013, Pages 100-111

  Djerada, Zoubir ^a   Feliu, Catherine ^a   Tournois, Claire ^a   Vautier, Damien ^a   Binet, Laurent ^a   Robinet, Arnaud ^a   Marty, Hélène ^a   Gozalo, Claire ^a   Lamiable, Denis ^a   Millart, Hervé ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Antiretrovirals; Antiviral; Boceprevir; Drug monitoring; Elvitegravir; UPLC MS MS

Indexed keywords

AMPRENAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; BOCEPREVIR; DARUNAVIR; EFAVIRENZ; ELVITEGRAVIR; ETRAVIRINE; INDINAVIR; LOPINAVIR; MARAVIROC; NEVIRAPINE; RALTEGRAVIR; RITONAVIR; SAQUINAVIR; TENOFOVIR; TIPRANAVIR;

ACCURACY; ARTICLE; BLOOD SAMPLING; CALIBRATION; DRUG BLOOD LEVEL; ELECTROSPRAY; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

ANTIRETROVIRAL DRUGS; ANTIRETROVIRALS; ANTIVIRAL; ARV; BOCEPREVIR; CT; DRUG MONITORING; ELVITEGRAVIR; INTERNAL STANDARD; IS; MRM; MULTIPLE REACTION TRANSITION; PLASMA TROUGH CONCENTRATION; TDM; THERAPEUTIC DRUG MONITORING; ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; UPLC-MS/MS;

ADENINE; ANTI-RETROVIRAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXANES; HUMANS; MASS SPECTROMETRY; ORGANOPHOSPHONATES; PROLINE; PYRIDAZINES; PYRROLIDINONES; QUINOLONES; TANDEM MASS SPECTROMETRY; TIME FACTORS; TRIAZOLES;

EID: 84883321963     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.08.002     Document Type: Article

References (29)

1. Higgins N., Tseng A., Sheehan N.L., la Porte C.J.L. Antiretroviral therapeutic drug monitoring in Canada: current status and recommendations for clinical practice. Canadian Journal of Hospital Pharmacy 2009, 62:500-509.
2. Yéni P. Prise en charge médicale des personnes infectées par le VIH 2010, http://www.sante.gouv.fr/IMG/pdf/Rapport_2010_sur_la_prise_en_charge_medicale_des_personnes_infectees_par_le_VIH_sous_la_direction_du_Pr-_Patrick_Yeni.pdf (Accessed july 2012) (n.d.).
3. Clumeck N., Pozniak A., Raffi F. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults. HIV Medicine 2008, 9:65-71.
4. Panel on Antiretroviral Guidelines for Adult and Adolescents, Exposure-Response Relationship and Therapeutic Drug Monitoring (TDM) for Antiretroviral Agents, Adult and Adolescent ARV Guidelines. (Accessed April 2013), AIDSinfo (n.d.). http://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv-guidelines/17/therapeutic-drug-monitoring.
5. Saint-Marcoux F., Sauvage F.-L., Marquet P. Current role of LC-MS in therapeutic drug monitoring. Analytical and Bioanalytical Chemistry 2007, 388:1327-1349.
6. Jung B.H., Rezk N.L., Bridges A.S., Corbett A.H., Kashuba A.D.M. Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry. Biomedical Chromatography 2007, 21:1095-1104.
7. Else L., Watson V., Tjia J., Hughes A., Siccardi M., Khoo S., et al. Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences 2010, 878:1455-1465.
8. Quaranta S., Woloch C., Paccou A., Giocanti M., Solas C., Lacarelle B. Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples. Therapeutic Drug Monitoring 2009, 31:695-702.
9. ter Heine R., Davids M., Rosing H., van Gorp E.C.M., Mulder J.W., van der Heide Y.T., et al. Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatography coupled with tandem mass spectrometry. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences 2009, 877:575-580.
10. Fayet A., Béguin A., Zanolari B., Cruchon S., Guignard N., Telenti A., et al. A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: raltegravir, maraviroc, darunavir, and etravirine. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences 2009, 877:1057-1069.
11. D'Avolio A., Simiele M., Siccardi M., Baietto L., Sciandra M., Oddone V., et al. A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation. Journal of Pharmaceutical and Biomedical Analysis 2011, 54:779-788.
12. D'Avolio A., De Nicolò A., Agnesod D., Simiele M., Mohamed Abdi A., Dilly Penchala S., et al. A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir. Journal of Pharmaceutical and Biomedical Analysis 2013, 78-79:217-223.
13. US Food and Drug Administration, Guidance for industry Bioanalytical method validation May 2001, http://www.hiv-druginteractions.org/ (Accessed July 2010) (n.d.).
14. Viswanathan C.T., Bansal S., Booth B., DeStefano A.J., Rose M.J., Sailstad J., et al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharmaceutical Research 2007, 24:1962-1973.
15. European Medicines Agency (EMA) Guideline on Bioanalytical Method Validation 21 July 2011, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf (Accessed June 2013) (n.d.).
16. Bonate P.L. Pharmacokinetic-Pharmacodynamic Modeling and Simulation 2011, Springer-Verlag Inc., New York. second ed.
17. Aouri M., Calmy A., Hirschel B., Telenti A., Buclin T., Cavassini M., et al. A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients. Journal of Mass Spectrometry 2013, 48:616-625.
18. D'Avolio A., Siccardi M., Sciandra M., Lorena B., Bonora S., Trentini L., et al. HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients. Journal of Chromatography B 2007, 859:234-240.
19. Yadav M., Singhal P., Goswami S., Pande U.C., Sanyal M., Shrivastav P.S. Selective determination of antiretroviral agents tenofovir, emtricitabine, and lamivudine in human plasma by a LC-MS-MS method for a bioequivalence study in healthy Indian subjects. Journal of Chromatographic Science 2010, 48:704-713.
20. Zhang L.J., Yao Y.M., Sun J.J., Chen J., Jia X.F., et al. An LC-MS/MS method for simultaneous quantification of seven anti-HIV medicines in plasma of HIV-infected patients. Pharmaceutica Analytica Acta 2010.
21. Elens L., Veriter S., Yombi J.C., Di Fazio V., Vanbinst R., Lison D., et al. Validation and clinical application of a high performance liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the quantitative determination of 10 anti-retrovirals in human peripheral blood mononuclear cells. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences 2009, 877:1805-1814.
22. The University of Liverpool and eMedFusion, Drug Interaction Charts. (Accessed April 2013) (n.d.). http://www.hiv-druginteractions.org/.
23. D'Avolio A., Siccardi M., Sciandra M., Baietto L., Lorena B., Bonora S., et al. HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences 2007, 859:234-240.
24. Ramanathan S., Mathias A.A., German P., Kearney B.P. Clinical pharmacokinetic and pharmacodynamic profile of the HIV integrase inhibitor elvitegravir. Clinical Pharmacokinetics 2011, 50:229-244.
25. ter Heine R., Alderden-Los C.G., Rosing H., Hillebrand M.J.X., van Gorp E.C.M., Huitema A.D.R., et al. Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2007, 21:2505-2514.
26. R.K. Valluru, P.B.R. B, K.S. S, P.K. V, N.B. Kilaru, High throughput LC-MS/MS method for simultaneous determination of tenofovir, lamivudine and nevirapine in human plasma, Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences 931 (2013) 117-126.
27. Gomes N.A., Vaidya V.V., Pudage A., Joshi S.S., Parekh S.A. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study. Journal of Pharmaceutical and Biomedical Analysis 2008, 48:918-926.
28. Matta M.K., Burugula L., Pilli N.R., Inamadugu J.K., SRJVLN A novel LC-MS/MS method for simultaneous quantification of tenofovir and lamivudine in human plasma and its application to a pharmacokinetic study. Biomedical Chromatography 2012, 26:1202-1209.
29. Takahashi M., Konishi M., Kudaka Y., Okumura N., Hirano A., Terahata N., et al. A conventional LC-MS method developed for the determination of plasma raltegravir concentrations. Biological and Pharmaceutical Bulletin 2008, 31:1601-1604.